Researcher: Platin, Nurgün
Loading...
Name Variants
Platin, Nurgün
Email Address
Birth Date
5 results
Search Results
Now showing 1 - 5 of 5
Publication Metadata only Complementary and alternative medicine use in colorectal cancer patients in seven European countries(Churchill Livingstone, 2005) Molassiotis, A; Fernandez-Ortega, P; Pud, D; Ozden, G; Hummerston, S; Scott, JA; Panteli, V; Gudmundsdottir, G; Selvekerova, S; Patiraki, E; Kearney, N; N/A; Platin, Nurgün; Faculty Member; School of Nursing; 191329Purpose: The aim of the present study was to examine the use of complementary and alternative medicine (CAM) in a sample of colorectal cancer patients in Europe. Methods: The study was a descriptive cross-sectional survey and data were collected through a 27-item self-reported questionnaire from seven European countries. Results: As part of a Larger study, 126 colorectal cancer patients participated in this survey. Among the participants, 32% used CAM after the diagnosis of cancer. Almost half the CAM therapies used were new therapies, never tried before the diagnosis. The most common CAM therapies included herbal medicine (48.7%), homeopathy (20.5%), use of vitamins/minerals (17.9%), spiritual therapies (15.4%), medicinal teas (15.4%) and relaxation techniques (12.8%). A dramatic increase was observed in the use of CAM from usage levels before the cancer diagnosis. High levels of satisfaction with CAM were also reported. Patients used CAM more often to increase the body's ability to fight the cancer or to improve physical welt-being. However, expectations did not always match with the benefits reported. Conclusions: As one-third of colorectal cancer patients use CAM, health professionals should be more aware of this approach to the patient's management. They should discuss the role of CAM therapies with their patients in a non-judgemental and open manner, and endeavour to provide accurate information in order to allow patients to make their own decision about CAM.Publication Metadata only Complementary and alternative medicine use in patients with head and neck cancers in Europe(BLACKWELL PUBLISHING, 2006) Molassiotis, A; Ozden, G; Scott, JA; Pud, D; Fernandez-Ortega, P; Milovics, L; Panteli, V; Gudmundsdottir, G; Browall, M; Madsen, E; Patiraki, E; Kearney, N; N/A; Platin, Nurgün; Faculty Member; School of Nursing; 191329The aim of the present study was to examine the patterns of complementary and alternative medicine (CAM) use in a sample of head and neck cancer patients, forming part of a larger study. A cross-sectional survey design was used collecting data through a descriptive 27-item questionnaire in nine countries in Europe. The participants were 75 patients with head and neck cancers. The prevalence rate of CAM use was 22.7%. The most common therapies used were herbal medicine (47%), medicinal teas (23.5%), use of vitamins/minerals (11.8%) and visualization (11.8%). Use of CAM dramatically increased after the diagnosis with cancer (i.e. eightfold increase in the use of herbs). A profile of CAM users was not evident in this sample. Patients used CAM for a variety of reasons together, with counteracting the ill effects from cancer and its treatment being the most common one. Information about CAM was obtained mostly from friends and family. As one in five head and neck cancer patients use CAM it is important that clinicians explore practices with their patients, improve communication about CAM with them and assist those who want to use CAM in using appropriate and safe therapies.Publication Metadata only Complementary and alternative medicine use in breast cancer patients in Europe(Springer, 2006) Molassiotis, A; Scott, JA; Kearney, N; Pud, D; Magri, M; Selvekerova, S; Bruyns, I; Fernadez-Ortega, P; Panteli, V; Margulies, A; Gudmundsdottir, G; Milovics, L; Ozden, G; Patiraki, E; N/A; Platin, Nurgün; Faculty Member; School of Nursing; 191329Complementary and alternative medicine (CAM) has gained popularity among cancer patients in the past years. For this study, CAM includes any group of health care systems, practices or products that are not considered to be part of conventional medicine at present (National Center for Complementary and Alternative Medicine). The present study assessed patterns of CAM use in breast cancer patients in Europe. The study used a descriptive cross-sectional design, and data were collected through a 27-item questionnaire. The sample, which was part of a larger study, consisted of 282 breast cancer patients from 11 countries in Europe. Among participants, 44.7% used CAM since their diagnosis of cancer. The most common therapies used included herbal medicine (46.4%) and medicinal teas, relaxation techniques, spiritual therapies, homeopathy and vitamins/minerals. Younger patients with higher education and who had received combination treatments for their cancer in the past were more likely to use CAM. High levels of satisfaction were reported, with only 6.5% of the women reporting no benefits from the CAM used. Main sources of information about CAM were mostly friends/family and the media. Findings suggested that a high proportion of breast cancer patients used CAM, which may have implications for the clinical management of these patients.Publication Metadata only Complementary and alternative medicine use in patients with haematological malignancies in Europe(Elsevier, 2005) Molassiotis, A.; Margulies, A.; Fernandez-Ortega, P.; Pud, D.; Panteli, V.; Bruyns, I.; Scott, J.A.; Gudmundsdottir, G.; Browall, M.; Madsen, E.; Ozden, G.; Magri, M.; Selvekerova, S.,; Kearney, N.; Patiraki, E.; N/A; Platin, Nurgün; Faculty Member; School of Nursing; 191329This study reports upon a descriptive cross-sectional survey assessing the use of complementary and alternative medicine (CAM) in patients with haematological cancers. Twelve European countries contributed data from patients with haematological cancers, as part of a larger study. Sixty-eight patients with haematological cancer participated. Among the participants, 26.5% used some form of CAM after the cancer diagnosis. The most common therapies used were homeopathy (38.9%), herbal medicine (22.2%) various psychic therapies, such as use of mediums, healers, rebirthing or past life regression therapy (22.2%). A particular profile of a CAM user was not evident in the sample. Moderate levels of satisfaction with CAM were reported. Patients commonly used CAM to increase the ability of their body to fight cancer and to improve physical and emotional well-being. Information about CAM was received mainly from friends or family. As CAM use in patients with haematological malignancies is common, clinicians should assist patients who want to use CAM to make an appropriate decision, and improve communication with them about CAM use in an open and non-judgemental dialogue.Publication Metadata only Complementary and alternative medicine use in lung cancer patients in eight European Countries(Elsevier, 2006) Molassiotis, A.; Panteli, V.; Patiraki, E.; Ozden, G.; Madsen, E.; Browall, M.; Fernandez-Ortega, P.; Pud, D.; Margulies, A.; N/A; Platin, Nurgün; Faculty Member; School of Nursing; 191329This paper presents findings from a cross-sectional survey about the use of complementary and alternative medicine (CAM) in patients with lung cancer, forming part of a larger study. Data from 111 lung cancer patients in 8 countries in Europe were collected through a descriptive 27-item questionnaire. The data suggest that 23.6% of the lung cancer patients used CAM after the diagnosis with cancer. The most popular CAM modalities were herbal medicine (48.1%), medicinal teas (11.5%), homeopathy (11.5%), use of animal extracts (11.5%) and spiritual therapies (11.5%). Herbal use increased by three times after the diagnosis of cancer. Patients seemed quite satisfied with the CAM used. They were also spending on average about 142 Euros monthly on CAM therapies or remedies. The most common motivation to use CAM was to increase the body's ability to fight the cancer. Main sources of information about CAM were friends and family. As CAM is increasingly used by patients with lung cancer, it is important to be able to assist patients make an appropriate decision by discussing the issue of CAM openly, providing reassurance and communicating safe and appropriate information to patients.